Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2012
10/25/2012US20120269734 Self-Illuminating Dot Systems and Methods of Use Thereof
10/25/2012US20120269733 Model Systems and Treatment Regimes for Treatment of Neurological Disease
10/25/2012US20120269732 Methods of controlling tumorigenesis and diagnosing the risk thereof
10/25/2012US20120269731 Polypeptides that home to atherosclerotic plaque
10/25/2012US20120269730 Intracellular Delivery of Contrast Agents with Functionalized Nanoparticles
10/25/2012US20120269729 Stabilized chitosan-based nanoparticles and methods for making the same
10/25/2012US20120269728 Methods and compositions for detecting one or more target agents using tracking components
10/25/2012US20120269725 Targeted radiolabeled compounds and their use for the treatment and diagnosis of cancer
10/25/2012US20120269723 Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
10/25/2012US20120269722 Chemoembolisation
10/25/2012US20120269721 Targeted nanoclusters and methods of their use
10/25/2012US20120269720 Detection of hepatic insulin resistance
10/25/2012DE10255601B4 Verwendung eines Triphenylmethanfarbstoffs zur Herstellung eines Färbemittels bei der Netzhaut- und Glaskörperchirurgie Using a triphenylmethane dye for producing a colorant in Vitreoretinal Surgery
10/24/2012EP2514442A2 Imaging diagnostics by combining contrast agents
10/24/2012EP2512992A1 Magnetite in nanoparticulate form
10/24/2012EP2512524A1 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri)
10/24/2012EP2512523A1 Labelled integrin binders
10/24/2012EP2512513A1 Nanoparticle clusters formed from individual nanoparticles of two or more types
10/24/2012CN102753201A Systems and methods for producing hyperpolarized materials and mixtures thereof
10/24/2012CN102743770A Targeting molecular imaging probe and living molecular imaging method
10/24/2012CN102743769A Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation
10/24/2012CN102743768A Stealth contrast-enhancing material for early diagnosis of tumors and preparation method thereof
10/24/2012CN102743762A Receptor-mediated quantum dot tracing targeted drug delivery system, preparation method thereof and application
10/24/2012CN102743761A System purification, detection and treatment
10/24/2012CN102743646A Medicinal composition for inspecting and preventing diabetes
10/24/2012CN102743327A Nano-scale artificial oil body for targeted drug delivery system detection and treatment
10/24/2012CN102743326A Nano-scale artificial oil body for targeted drug delivery system detection and treatment
10/24/2012CN102743325A Nano-scale artificial oil body for targeted drug delivery system detection and treatment
10/24/2012CN102743324A Nano-scale artificial oil body for targeted drug delivery system detection and treatment
10/24/2012CN102166365B Preparation method of multiplex-mode iodized oil nano-emulsion contrast medium
10/23/2012US8293212 Inhibitor screening method and atopic dermatitis like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte and utilization of same
10/23/2012US8293211 CB1 receptor antagonists and uses thereof
10/23/2012CA2549141C Novel differential imaging method
10/23/2012CA2454275C Conformationally constrained parathyroid hormone (pth) analogs
10/23/2012CA2373475C Novel cyanine and indocyanine dye bioconjugates for biomedical applications
10/23/2012CA2219119C Nucleic acid ligand complexes
10/18/2012WO2012142138A2 Cuinse/zns nir-quantum dots (qds) for biomedical imaging
10/18/2012WO2012102799A3 Method, composition and package for bowel cleansing
10/18/2012WO2012091452A3 Biocompatible agent for dispersing nanoparticles into an aqueous medium using mussel adhesive protein-mimetic polymer
10/18/2012WO2012003478A3 Detecting targets using mass tags and mass spectrometry
10/18/2012US20120264141 Tuberculosis diagnostic test
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/18/2012US20120263654 Melanoma specific biomarker
10/18/2012US20120263653 Methods and systems for generating nanoparticles
10/18/2012US20120263652 Targeted carriers for drug delivery across the gastrointestinal epithelium
10/18/2012US20120263651 Single Stranded DNA Aptamers Binding NF-kB/RelA
10/18/2012US20120263650 Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders
10/18/2012US20120263649 Detection of mycobacteria
10/18/2012US20120263648 Rna nanoparticles and nanotubes
10/18/2012US20120263647 Pro104 Antibody Compositions and Methods of Use
10/18/2012US20120263643 Brachytherapy seed
10/18/2012CA2836299A1 Clonal strains of attenuated vaccinia viruses and methods of use thereof
10/17/2012EP2509620A2 Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
10/17/2012EP2509618A2 Systemic administration of an agent that permeabilises tumour vasculature
10/17/2012CN102740875A Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
10/17/2012CN102740768A Magnetic probe apparatus
10/17/2012CN102735752A Tumor-targeting living body multimodality imaging method based on gold nano-clusters
10/17/2012CN102727912A Medical disinfecting ultrasound coupling gel and production process thereof
10/17/2012CN102727911A Diamino polyethylene glycol modified paramagnetic metal complex magnetic resonance imaging contrast agent
10/17/2012CN102727910A Method for screening sensitive type intractable epilepsy medicine
10/17/2012CN102727875A Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
10/17/2012CN102002117B Branched chitosan derivative and preparation method thereof
10/17/2012CN101980703B Self-destructing transdermal therapeutic system having improved functionality and efficacy
10/16/2012US8290556 Device, system and method for in-vivo analysis
10/16/2012US8288590 N-substituted monomers and polymers
10/16/2012US8287886 Tuberculosis vaccine
10/16/2012US8287483 Method and apparatus for enhancement of transdermal transport
10/16/2012CA2577550C Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma
10/16/2012CA2560892C Magnetic nanoparticles of noble metals
10/16/2012CA2527196C Diagnostic method for atherosclerosis
10/11/2012WO2012139080A2 Lipid-based nanoparticles
10/11/2012WO2012139030A1 Polymalic acid based nanoconjugates for imaging
10/11/2012WO2012137999A1 High-sensitivity magnetic resonance imaging nano-contrast agent based on an anionic polymer and cationic polymer ion complex, and a production method therefor
10/11/2012WO2012136958A2 Optical imaging probes
10/11/2012WO2012136813A2 Agents for medical radar diagnosis
10/11/2012WO2012135937A1 Protein kinase inhibitors
10/11/2012US20120260355 Method for Evaluating Inhibitory Polynucleotide Efficiency and Efficacy
10/11/2012US20120260354 Use of K2P Potassium Channel Activators as Antalgics
10/11/2012US20120259152 Treatment of hypoxic tumors with localized oxygenation
10/11/2012US20120258051 Multistrata nanoparticles and methods for making multistrata nanoparticles
10/11/2012US20120258050 13c-mr detection using hyperpolarised 13c-fructose
10/11/2012US20120258048 Optical fluorescent imaging
10/11/2012US20120258047 Epsilon-poly-lysine capsules
10/11/2012US20120258046 Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
10/11/2012US20120258045 Inhibitors and methods of treatment of cardiovascular diseases, and methods for identifying inhibitors
10/11/2012US20120258044 Lipid-based nanoparticles
10/11/2012US20120258043 Linkable Lewis X Analogs
10/11/2012US20120258038 Uses of apoptotic cell-targeting peptides, label substances and liposomes containing a therapeutic agent for preventing, treating or therapeutically diagnosing apoptosis-related diseases
10/11/2012CA2832484A1 Polymalic acid based nanoconjugates for imaging
10/11/2012CA2832106A1 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012CA2831843A1 Protein kinase inhibitors
10/11/2012CA2831480A1 Lipid-based nanoparticles
10/11/2012CA2831205A1 Optical imaging probes
10/10/2012EP2508171A1 Pharmaceutical magnetic nano-particle composition
10/10/2012EP2507220A1 Heterocycle-substituted xanthene dyes
10/10/2012EP2506763A1 Magnetic probe apparatus
10/10/2012CN1359301B Pharmaceutical composition comprising antibody specifically binding epitope in A-beta-10 residual group and its application
10/10/2012CN102725312A Protein agent for diabetes treatment and beta cell imaging
10/10/2012CN102724964A Process for the preparation of gadobenate dimeglumine complex in a solid form
10/10/2012CN102719403A A human pancreas adenosquamous carcinoma cell line and establishing method and application thereof
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 354